1. Home
  2. PLSE vs OGN Comparison

PLSE vs OGN Comparison

Compare PLSE & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

N/A

Current Price

$45.10

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.90

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLSE
OGN
Founded
2014
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PLSE
OGN
Price
$45.10
$13.90
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
★ $67.67
$10.33
AVG Volume (30 Days)
365.7K
★ 2.4M
Earning Date
11-05-2026
10-30-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.56
Revenue
N/A
★ $6,216,000,000.00
Revenue This Year
$406.29
N/A
Revenue Next Year
$157.24
$2.07
P/E Ratio
★ N/A
$8.92
Revenue Growth
★ N/A
N/A
52 Week Low
$12.95
$5.69
52 Week High
$58.94
$13.94

Technical Indicators

Market Signals
Indicator
PLSE
OGN
Relative Strength Index (RSI) 39.93 63.29
Support Level $43.32 $13.76
Resistance Level $57.14 N/A
Average True Range (ATR) 4.43 0.04
MACD -1.23 0.00
Stochastic Oscillator 13.61 80.56

Price Performance

Historical Comparison
PLSE
OGN

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: